As of 9:30 AM on the 6th, Celltrion is trading at 273,000 KRW, up 0.37% from the previous day. This marks a 14.95% increase compared to October 22. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Over the past five days, individual investors have net purchased 61,084 shares, while foreigners and institutions have net sold 247,770 shares and net purchased 153,887 shares, respectively.


On November 3, Celltrion was a market topic with the headline "Strong performance due to supplying COVID-19 test kits worth 210 billion KRW to the US."



※Source: AI Investment Assistant AI Rasero


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing